Postmortem evaluation of Alzheimer's disease

Area of Science:

• Neuropathology
• Clinical Neurology
• Geriatric Medicine

Background:

• Alzheimer's disease (AD) diagnosis relies on clinical assessment, but postmortem confirmation is crucial for validating accuracy.
• Neuropathological hallmarks of AD include neuritic plaques, neurofibrillary tangles, and vascular amyloid.

Purpose of the Study:

• To evaluate the diagnostic accuracy of clinical assessments for Alzheimer's disease (AD) through postmortem examination.
• To correlate clinical diagnoses with specific neuropathological findings in AD patients.

Main Methods:

• Postmortem brain evaluation of ten individuals diagnosed with Alzheimer's disease (AD).
• Comparison with a matched control group to identify differences in neuropathology.
• Analysis of clinical data and correlation with autopsy findings.

Main Results:

• AD patients exhibited significant ventricular dilatation, reduced brain mass, and increased neuritic plaques, neurofibrillary tangles, vascular amyloid, and Lewy bodies.
• Control subjects had fewer or no cortical plaques and tangles; two controls with rare plaques had dementia.
• Pneumonia and respiratory failure were more common in AD patients, while cancer and cardiovascular disease were more prevalent in controls.

Conclusions:

• Clinical assessment demonstrates high accuracy in diagnosing Alzheimer's disease (AD).
• Postmortem findings validate the clinical diagnosis and highlight the characteristic neuropathology of AD.
• Comorbidities differ between AD patients and controls, with implications for patient care.